Literature DB >> 17765769

Planned neck dissection after definitive radiotherapy or chemoradiation for base of tongue cancers.

Ying J Hitchcock1, Brandon G Bentz, Pramod K Sharma, Christine Fang, Jonathan D Tward, Lisa Pappas, Jergin Chen, John K Hayes, Dennis C Shrieve.   

Abstract

OBJECTIVES: The study goal was to analyze the role of planned neck dissection for squamous cell carcinoma of the base of the tongue treated with definitive radiotherapy or chemoradiation. STUDY DESIGN,
SETTING: We conducted a retrospective study of patients with squamous cell carcinoma of the base of the tongue undergoing planned neck dissection after definitive radiotherapy or chemoradiation.
RESULTS: Twenty-two of 41 (53.7%) patients had one to six positive residual lymph nodes after receiving definitive radiotherapy or chemoradiation. Neck control rates were 92.3% and 88.3% at two and five years, respectively. Three of 22 (13.6%) patients with pathological residual nodal disease had regional or locoregional failures, compared with 1 of 19 (5.3%) patients with a pathologically complete response (P = 0.39).
CONCLUSIONS: We observed a high incidence of pathologically residual lymph nodes after definitive radiotherapy or chemoradiation. SIGNIFICANCE: Planned neck dissection following definitive radiotherapy or chemoradiation is highly effective in achieving regional control of squamous cell carcinoma of the base of the tongue.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17765769     DOI: 10.1016/j.otohns.2007.03.008

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  2 in total

1.  Survival patterns in patients with carcinoma base of tongue treated with external beam irradiation and salvage surgery.

Authors:  Jaimanti Bakshi; Naresh K Panda; Sushmita Ghoshal; Vikas I Nehru
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2010-09-24

2.  Clinical outcomes associated with evolving treatment modalities and radiation techniques for base-of-tongue carcinoma: thirty years of institutional experience.

Authors:  Leechuan Andy Chen; Christopher J Anker; Jason P Hunt; Luke O Buchmann; Kenneth F Grossmann; Kenneth Boucher; Li-Ming Christine Fang; Dennis C Shrieve; Ying J Hitchcock
Journal:  Cancer Med       Date:  2015-01-26       Impact factor: 4.452

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.